Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy

Clinical Nuclear Medicine

Volumn 22, Issue 9, 1997, Pages 615-620

  Breitz, Hazel B ^a   Tyler, Andrea ^a   Bjorn, Michael J ^b   Lesley, Terry ^b   Weiden, Paul L ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b Poniard Pharmaceuticals Inc   (United States)

Author keywords

Monoclonal Antibody; Radioimmunoscintigraphy; Tc 99m Fab Fragment

Indexed keywords

ANTIBODY CONJUGATE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY TC 99M; NOFETUMOMAB MERPENTAN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; ANTIBODY LABELING; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER STAGING; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PANCREAS ADENOCARCINOMA; RADIOIMMUNOTHERAPY; SCINTILLATION CAMERA; WHOLE BODY SCINTISCANNING;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CARCINOMA; COLONIC NEOPLASMS; FEMALE; GAMMA CAMERAS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; SKIN NEOPLASMS; STOMACH NEOPLASMS; TECHNETIUM; TISSUE DISTRIBUTION; URINARY BLADDER NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 0031472730     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199709000-00007     Document Type: Article

References (17)

1. Larson SM, Brown JP, Wright BW, Carasquillo JA, Hellstrom I, Hellstrom KE: Imaging of melanoma with I-131-labeled antibodies. J Nucl Med 127:539, 1983.
2. Nabi HA, Doerr RJ: Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspectives. Am J Surg 163:448, 1992.
3. 111In-CYT-103 immunoscintigraphy in ovarian cancer. Gynecol Oncol 48:285, 1993.
4. Collier BD, Abdel-Nabi H, Doerr RJ, et al: Immunoscintigraphy performed with In-111-labded CYT-103 in the management of colorectal cancer: comparison with CT, Radiology 185:179, 1992.
5. Moffat FL, Pinsky CM, Hammershaimb L, et al: The Immuno-medies Study group. Clinical utility of external immuno-scintigraphy with IMMU-4 technetium 99m-Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum. Results of a Phase III trial. J Clin Oncol 14:2295, 1996.
6. Bjorn MJ, Manger R, Sivan G, Morgan AC, Torok-Storb B: Selective elimination of breast cancer cells from human bone marrow using an Antibody-Pseudomonas exotoxin A conjugate. Cancer Res 50:5992, 1990.
7. Pearson JW, Sivam G, Manger R, Wiltrout R, Morgan AC, Longo D: Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice. Cancer Res 49:4990, 1989.
8. Abrams P, Fer M, Faubion C, et al: A new procedure for staging small cell lung cancer (SCLC): gamma camera imaging using a technetium-99m labeled monoclonal antibody Fab. Am Soc Clin Oncol 9:A895, 1990.
9. Balaban EP, Walker BS, Cox JV, et al: Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma. Clin Nucl Med 16:732, 1991.
10. Morris JF, Krishnamurthy S, Antonovic R, Duncan C, Turner FE, Krishnamurthy GT: Technetium-99m monoclonal antibody fragment (FAb) scintigraphy in the evaluation of small cell lung cancer; A preliminary report. Nucl Med Biol 18:613, 1991.
11. Friedman S, Sullivan K, Salk D, et al: Staging non-small cell carcinoma of the lung using Technetium-99m-labeled monoclonal antibodies, Hematology/Oncology Clin North Am 4:1069, 1990.
12. Vansant JP, Johnson DH, O'Donnell DM, et al: Staging lung carcinoma with a Tc-99m labeled monoclonal antibody. Clin Nucl Med 17:431, 1992.
13. Rusch V, Macapinlac H, Heelan R, et al: NR-LU-10 Monoclonal antibody scanning: A helpful new adjunct to CT in evaluating non-small cell lung cancer, J Thorac Cardiovasc Surg 106:200, 1993.
14. 186Rhenium Labeled monoclonal antibodies for radioimmunotherapy: Results of phase 1 trials, J Nucl Med 33; 1099, 1992.
15. Weiden PL, Breitz HB, Seiler CA, et al: Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10, J Nucl Med 34:2111, 1993.
16. Kasina S, Rao TN, Srinivasan A, et al: Development of a biological evaluation kit for preformed chelate: Tc-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. J Nucl Med 32:1445, 1991.
17. Fritzberg AR, Abrams PG, Beaumier PL, et al: Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc Natl Acad Sci 85:4025, 1988.